A BRIEF REVIEW ON CONVENTIONAL TREATMENT OF HEAD AND NECK CANCER

Abstract

HNCs are a serious public health concern because of their steadily increasing occurrence. Five-year survival rates are still low despite standard treatment choices such as surgery, chemotherapy, and radiation therapy because of resistance to these treatments, local recurrence, local lymph node metastasis, and, in some more advanced instances, distant metastasis. As a result, patients with HNCs have a higher chance of dying and a lower quality of life because of the negative consequences of radiation and chemotherapy. Additionally, immunotherapies and targeted medicines have frequently demonstrated low efficacy due to problems with resistance and treatment accessibility. In order to better treat HNC patients, various approaches are being investigated, such as those based on combination therapy and nanotechnology.